AD is characterized by progressive cognitive decline associated with the accumulation of amyloid beta (Aβ) plaques, tau hyperphosphorylation, synaptic dysfunction, and neurodegeneration [84]. The gene discussed is MAPT; the disease is Alzheimer disease.